Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Times Interest Earned (2016 - 2025)

Amicus Therapeutics filings provide 16 years of Times Interest Earned readings, the most recent being $1.4 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 4.47% to $1.4 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.71, a 41.63% increase, with the full-year FY2025 number at $0.71, up 41.63% from a year prior.
  • Times Interest Earned hit $1.4 in Q4 2025 for Amicus Therapeutics, down from $2.93 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $2.93 in Q3 2025 to a low of -$9.25 in Q1 2022.
  • Median Times Interest Earned over the past 5 years was -$1.87 (2024), compared with a mean of -$2.54.
  • Biggest five-year swings in Times Interest Earned: soared 564.02% in 2024 and later crashed 168.48% in 2025.
  • Amicus Therapeutics' Times Interest Earned stood at -$8.84 in 2021, then surged by 56.83% to -$3.82 in 2022, then surged by 92.46% to -$0.29 in 2023, then soared by 564.02% to $1.34 in 2024, then rose by 4.47% to $1.4 in 2025.
  • The last three reported values for Times Interest Earned were $1.4 (Q4 2025), $2.93 (Q3 2025), and -$0.82 (Q2 2025) per Business Quant data.